| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52679-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75908-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81270SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12035-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35121-10ug | |||
| Carrier-Free | NBP2-35121-1mg | |||
| Carrier-Free | NBP2-35121-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2730-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35307-10ug | |||
| Carrier-Free | NBP2-35307-1000ug | |||
| Carrier-Free | NBP2-35307-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35024-10ug | |||
| Carrier-Free | NBP2-35024-1mg | |||
| Carrier-Free | NBP2-35024-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75198-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34950-10ug | |||
| Carrier-Free | NBP2-34950-1mg | |||
| Carrier-Free | NBP2-34950-500ug | |||
![Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.](http://images.novusbio.com/fullsize/CCR4-Antibody-KW-0761-Mogamulizumab-Chimeric-Western-Blot-NBP2-81270-img0001.jpg "Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.")
![Flow Cytometry: IL-17/IL-17A Antibody (MM17F3) - Chimeric [NBP3-12035] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MM17F3 (NBP3-12035, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-MM17F3-Chimeric-Flow-Cytometry-NBP3-12035-img0001.jpg "Flow Cytometry: IL-17/IL-17A Antibody (MM17F3) - Chimeric [NBP3-12035] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MM17F3 (NBP3-12035, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Mouse IL-21 Protein [NBP2-35121]](http://images.novusbio.com/fullsize/Mouse-IL-21-Protein-SDS-Page-NBP2-35121-img0001.jpg "SDS-Page: Mouse IL-21 Protein [NBP2-35121]")
![SDS-Page: Recombinant Human IL-2 [ Cys Ser125]Protein [NBP3-07100] - Western blot under reducing and non-reducing conditions](http://images.novusbio.com/fullsize/Recombinant Human IL-2 [ Cys Ser125]Protein-SDS-Page-NBP3-07100-img0001.jpg "SDS-Page: Recombinant Human IL-2 [ Cys Ser125]Protein [NBP3-07100] - Western blot under reducing and non-reducing conditions")
![SDS-Page: Recombinant Human Lymphotoxin-alpha/TNF-beta Protein [NBP2-61307]](http://images.novusbio.com/fullsize/Recombinant-Human-Lymphotoxin-alpha-TNF-beta-Protein-SDS-Page-NBP2-61307-img0002.jpg "SDS-Page: Recombinant Human Lymphotoxin-alpha/TNF-beta Protein [NBP2-61307]")
![SDS-Page: Primate IL-1 beta/IL-1F2 Protein [NBP2-35307]](http://images.novusbio.com/fullsize/Primate-IL-1-beta-IL-1F2-Protein-SDS-Page-NBP2-35307-img0001.jpg "SDS-Page: Primate IL-1 beta/IL-1F2 Protein [NBP2-35307]")
![SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]](http://images.novusbio.com/fullsize/Recombinant-Human-IL-13-Variant-Protein-SDS-Page-NBP2-35024-img0002.jpg "SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]")
![ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.](http://images.novusbio.com/fullsize/nbp2-75198_rabbit-monoclonal-cd27-tnfrsf7-antibody-rm27-3e5-chimeric-7420252228563.png "ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.")
![SDS-Page: Equine IL-2 Protein [NBP2-34950]](http://images.novusbio.com/fullsize/Equine-IL-2-Protein-SDS-Page-NBP2-34950-img0001.jpg "SDS-Page: Equine IL-2 Protein [NBP2-34950]")